Abstract
In China, the traditional Chinese medicine “YiSui ShenXu Granule” has been used for treating β-thalassemia over 20 years and known to be effective in clinic. Several purified components from “YiSui ShenXu Granule” are tested in K562 cells to reveal its effect on globin expression and erythroid differentiation, and one of the purified components, emodin, was demonstrated to increase the expression of α-, ε-, γ-globin, CD235a, and CD71 in K562 cells. Moreover, the increase of their expression is emodin concentration-dependent. The mRNA and microRNA (miRNA) expression profiles are further analyzed and 417 mRNAs and 35 miRNAs with differential expression between untreated and emodin-treated K562 cells were identified. Among them, two mRNAs that encode known positive regulators of erythropoiesis, ALAS2, and c-KIT respectively, increased during emodin-induced K562 erythroid differentiation, meanwhile, two negative regulators, miR-221 and miR-222, decreased during this process. These results indicate that emodin can improve the expression of globin genes in K562 cells and also induce K562 cells to erythroid differentiation possibly through up-regulating ALAS2 and c-KIT and down-regulating miR-221 and miR-222.
Similar content being viewed by others
References
Ley TJ, DeSimone J, Anagnou NP, Keller GH, Humphries RK, Turner PH, Young NS, Keller P, Nienhuis AW (1982) 5-azacytidine selectively increases gamma-globin synthesis in a patient with beta + thalassemia. N Engl J Med 307:1469–1475
Nienhuis AW, Ley TJ, Humphries RK, Young NS, Dover G (1985) Pharmacological manipulation of fetal hemoglobin synthesis in patients with severe beta-thalassemia. Ann N Y Acad Sci 445:198–211
Liu DP, Liang CC, Ao ZH, Jia PC, Chen SS, Wang RX, Liu LJ, Jin HQ, Zha DY, Huang YW (1990) Treatment of severe beta-thalassemia (patients) with myleran. Am J Hematol 33:50–55
Perrine SP, Miller BA, Faller DV, Cohen RA, Vichinsky EP, Hurst D, Lubin BH, Papayannopoulou T (1989) Sodium butyrate enhances fetal globin gene expression in erythroid progenitors of patients with Hb SS and beta thalassemia. Blood 74:454–459
Chalevelakis G, Yalouris AG, Lyberatos C, Economopoulos T, Anastasiou C, Hatziioannou J, Raptis S (1989) Effect of isoniazid, a haem inhibitor, on globin chain synthesis in reticulocytes from non-thalassaemic and beta thalassaemic subjects. J Clin Pathol 42:977–981
Wu ZK, Zhang XH, Li M (2006) Clinical observation on effects of Yisui Shengxue Granule in treating 156 patients with beta-thalassemia. Zhongguo Zhong Xi Yi Jie He Za Zhi 26:352–354
Zhang L, Lau YK, Xi L, Hong RL, Kim DS, Chen CF, Hortobagyi GN, Chang C, Hung MC (1998) Tyrosine kinase inhibitors, emodin and its derivative repress HER-2/neu-induced cellular transformation and metastasis-associated properties. Oncogene 16:2855–2863
Pecere T, Gazzola MV, Mucignat C, Parolin C, Vecchia FD, Cavaggioni A, Basso G, Diaspro A, Salvato B, Carli M, Palù G (2000) Aloe-emodin is a new type of anticancer agent with selective activity against neuroectodermal tumors. Cancer Res 60:2800–2804
Feng Y, Huang SL, Dou W, Zhang S, Chen JH, Shen Y, Shen JH, Leng Y (2010) Emodin, a natural product, selectively inhibits 11beta-hydroxysteroid dehydrogenase type 1 and ameliorates metabolic disorder in diet-induced obese mice. Br J Pharmacol 161:113–126
Bakker WJ, Blázquez-Domingo M, Kolbus A, Besooyen J, Steinlein P, Beug H, Coffer PJ, Löwenberg B, von Lindern M, van Dijk TB (2004) FoxO3a regulates erythroid differentiation and induces BTG1, an activator of protein arginine methyl transferase 1. J Cell Biol 164:175–184
Marinkovic D, Zhang X, Yalcin S, Luciano JP, Brugnara C, Huber T, Ghaffari S (2007) Foxo3 is required for the regulation of oxidative stress in erythropoiesis. J Clin Invest 117:2133–2144
Filipe A, Li Q, Deveaux S, Godin I, Romeo PH, Stamatoyannopoulos G, Mignotte V (1999) Regulation of embryonic/fetal globin genes by nuclear hormone receptors: a novel perspective on hemoglobin switching. EMBO J 18:687–697
Wang D, Li Y, Shen B (2002) A novel erythroid differentiation related gene EDRF1 upregulating globin gene expression in HEL cells. Chin Med J (Engl) 115:1701–1705
Zhang FL, Shen GM, Liu XL, Wang F, Zhao HL, Yu J, Zhang JW (2011) Hypoxic induction of human erythroid-specific δ-aminolevulinate synthase mediated by hypoxia-inducible factor 1. Biochemistry 50:1194–1202
Kawano T, Horiguchi-Yamada J, Saito S, Iwase S, Furukawa Y, Kano Y, Yamada H (2004) Ectopic cyclin D1 expression blocks STI571-induced erythroid differentiation of K562 cells. Leuk Res 28:623–629
Duff C, Smith-Miles K, Lopes L, Tian T (2012) Mathematical modelling of stem cell differentiation: the PU.1-GATA-1 interaction. J Math Biol 64:449–468
Fernández-Nestosa MJ, Hernández P, Schvartzman JB, Krimer DB (2008) PU.1 is dispensable to block erythroid differentiation in Friend erythroleukemia cells. Leuk Res 32:121–130
Lorsbach RB, Moore J, Ang SO, Sun W, Lenny N, Downing JR (2004) Role of RUNX1 in adult hematopoiesis: analysis of RUNX1-IRES-GFP knock-in mice reveals differential lineage expression. Blood 103:2522–2529
Yokomizo T, Hasegawa K, Ishitobi H, Osato M, Ema M, Ito Y, Yamamoto M, Takahashi S (2008) Runx1 is involved in primitive erythropoiesis in the mouse. Blood 111:4075–4080
Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297
Borel C, Deutsch S, Letourneau A, Migliavacca E, Montgomery SB, Dimas AS, Vejnar CE, Attar H, Gagnebin M, Gehrig C, Falconnet E, Dupré Y, Dermitzakis ET, Antonarakis SE (2011) Identification of cis- and trans-regulatory variation modulating microRNA expression levels in human fibroblasts. Genome Res 21:68–73
Macfarlane LA, Murphy PR (2010) MicroRNA: biogenesis, Function and Role in Cancer. Curr Genomics 11:537–561
Zhan M, Miller CP, Papayannopoulou T, Stamatoyannopoulos G, Song CZ (2007) MicroRNA expression dynamics during murine and human erythroid differentiation. Exp Hematol 35:1015–1025
Sankaran VG, Menne TF, Šćepanović D, Vergilio JA, Ji P, Kim J, Thiru P, Orkin SH, Lander ES, Lodish HF (2011) MicroRNA-15a and -16–1 act via MYB to elevate fetal hemoglobin expression in human trisomy 13. Proc Natl Acad Sci USA 108:1519–1524
Gabbianelli M, Testa U, Morsilli O, Pelosi E, Saulle E, Petrucci E, Castelli G, Giovinazzi S, Mariani G, Fiori ME, Bonanno G, Massa A, Croce CM, Fontana L, Peschle C (2010) Mechanism of human Hb switching: a possible role of the kit receptor/miR 221–222 complex. Haematologica 95:1253–1260
Felli N, Fontana L, Pelosi E, Botta R, Bonci D, Facchiano F, Liuzzi F, Lulli V, Morsilli O, Santoro S, Valtieri M, Calin GA, Liu CG, Sorrentino A, Croce CM, Peschle C (2005) MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc Natl Acad Sci USA 102:18081–18086
Lu L, Dai MS, Ge Y, Wang LS, Braun SE, Wait CL, Griffith DJ, Heinrich MC, Broxmeyer HE (2000) Co-transduction of cDNAs for c-kit and steel factor into single CD34+ cord blood cells further enhances the growth of erythroid and multipotential progenitors. J Hematother Stem Cell Res 9:813–825
Dai MS, Heinrich MC, Broxmeyer HE, Lu L (2000) Enhancing effects of co-transduction of both human erythropoietin receptor and c-kit cDNAs into hematopoietic stem/progenitor cells from cord blood on proliferation and differentiation of erythroid progenitors. Cytokines Cell Mol Ther 6:1–8
Kucerova J, Horvathova M, Mojzikova R, Belohlavkova P, Cermak J, Divoky V (2011) New mutation in erythroid-specific delta-aminolevulinate synthase as the cause of X-linked sideroblastic anemia responsive to pyridoxine. Acta Haematol 125:193–197
Whatley SD, Ducamp S, Gouya L, Grandchamp B, Beaumont C, Badminton MN, Elder GH, Holme SA, Anstey AV, Parker M, Corrigall AV, Meissner PN, Hift RJ, Marsden JT, Ma Y, Mieli-Vergani G, Deybach JC, Puy H (2008) C-terminal deletions in the ALAS2 gene lead to gain of function and cause X-linked dominant protoporphyria without anemia or iron overload. Am J Hum Genet 83:408–414
Liu YM, Wu ZK, Chai LM, Zhang XH, Li M, Chen YY, Lv XX, Zhu XY (2007) Effect on expression of mice alpha-hemoglobin stabilizing protein in different developmental stages treated with Yisui Shengxue granules. Zhongguo Zhong Yao Za Zhi 32:609–612
Zhang C, Wu ZK (2008) Molecular pharmacological basis of the YiSui ShenXu Granule in beta-thalassemia therapy. J Ethnopharmacol 120:437–441
Kramer MF, Gunaratne P, Ferreira GC (2000) Transcriptional regulation of the murine erythroid-specific 5-aminolevulinate synthase gene. Gene 247:153–166
Tripic T, Deng W, Cheng Y, Zhang Y, Vakoc CR, Gregory GD, Hardison RC, Blobel GA (2009) SCL and associated proteins distinguish active from repressive GATA transcription factor complexes. Blood 113:2191–2201
Kaneko H, Shimizu R, Yamamoto M (2010) GATA factor switching during erythroid differentiation. Curr Opin Hematol 17:163–168
Liberati C, Cera MR, Secco P, Santoro C, Mantovani R, Ottolenghi S, Ronchi A (2001) Cooperation and competition between the binding of COUP-TFII and NF-Y on human epsilon- and gamma-globin gene promoters. J Biol Chem 276:41700–41709
Aerbajinai W, Zhu J, Kumkhaek C, Chin K, Rodgers GP (2009) SCF induces gamma-globin gene expression by regulating downstream transcription factor COUP-TFII. Blood 114:187–194
Acknowledgments
This work was supported by grants from the National Basic Research Program of China (2010CB530406) and the National Natural Science Foundation of China (31201103).
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Additional information
Yan-Ni Ma and Ming-Tai Chen contributed to this work equally.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Ma, YN., Chen, MT., Wu, ZK. et al. Emodin can induce K562 cells to erythroid differentiation and improve the expression of globin genes. Mol Cell Biochem 382, 127–136 (2013). https://doi.org/10.1007/s11010-013-1726-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-013-1726-3